BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18705415)

  • 21. Synchronous double primary malignancies of the pancreatic body and extrahepatic bile duct treated with pancreatoduodenectomy and splenic artery resection following neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel: a case report.
    Murokawa T; Okabayashi T; Sui K; Tabuchi M; Iwata J
    Surg Case Rep; 2022 Feb; 8(1):29. PubMed ID: 35171354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A Case of Resected Combined Pancreatic Mixed Ductal Adenocarcinoma and Neuroendocrine Tumor].
    Hashimoto K; Seto H; Adachi K; Nonaka R; Fujie Y; Moon JH; Fujita S; Kojima K; Hanai J; Imaoka S; Ohnishi T
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2159-2161. PubMed ID: 30692317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
    Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
    Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
    J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cephalic pancreaticoduodenectomy for adenocarcinoma of the head of the pancreas: does pylorus preservation change morbidity and prognosis?].
    Pirro N; Sielezneff I; Cesari J; Consentino B; Gregoire R; Brunet C; Sastre B
    Ann Chir; 2002 Feb; 127(2):95-100. PubMed ID: 11885380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
    Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
    World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resection of four synchronous invasive ductal carcinomas in the pancreas head and body associated with pancreatic intraepithelial neoplasia: report of a case.
    Izumi S; Nakamura S; Mano S; Suzuka I
    Surg Today; 2009; 39(12):1091-7. PubMed ID: 19997809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.
    Chatterjee D; Katz MH; Rashid A; Varadhachary GR; Wolff RA; Wang H; Lee JE; Pisters PW; Vauthey JN; Crane C; Gomez HF; Abbruzzese JL; Fleming JB; Wang H
    Cancer; 2012 Jun; 118(12):3182-90. PubMed ID: 22028089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
    Nanashima A; Tobinaga S; Abo T; Hatano K; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Case of Long-Term Survival after Total Pancreatectomy for Recurrent Pancreatic Cancer in the Remnant Pancreas after Pancreatoduodenectomy].
    Miyamoto A; Hama N; Maeda S; Hamakawa T; Uemura M; Miyake M; Nishikawa K; Miyazaki M; Kato T; Hirao M; Sekimoto M; Nakamori S
    Gan To Kagaku Ryoho; 2019 Feb; 46(2):330-332. PubMed ID: 30914550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pylorus-preserving pancreaticoduodenectomy versus conventional whipple operation.
    Di Carlo V; Zerbi A; Balzano G; Corso V
    World J Surg; 1999 Sep; 23(9):920-5. PubMed ID: 10449821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indocyanine Green-Enhanced Fluorescence in Laparoscopic Duodenum-Preserving Pancreatic Head Resection: Technique with Video.
    Chen S; Gao P; Cai H; Cai Y; Wang X; Peng B
    Ann Surg Oncol; 2020 Oct; 27(10):3926-3927. PubMed ID: 32266569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
    White RR; Xie HB; Gottfried MR; Czito BG; Hurwitz HI; Morse MA; Blobe GC; Paulson EK; Baillie J; Branch MS; Jowell PS; Clary BM; Pappas TN; Tyler DS
    Ann Surg Oncol; 2005 Mar; 12(3):214-21. PubMed ID: 15827813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Total pancreatectomy for pancreatic head cancer accompanied with multiple lesions].
    Toshiyama R; Yokoyama S; Hashimoto K; Takeda M; Matsumoto S; Fukuda S; Naito A; Tokuoka M; Matsuyama J; Ide Y; Morimoto T; Fukushima Y; Nomura T; Kodama K; Shiba I; Takeda M; Sasaki Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2137-9. PubMed ID: 23268002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.
    Yeo CJ; Cameron JL; Lillemoe KD; Sitzmann JV; Hruban RH; Goodman SN; Dooley WC; Coleman J; Pitt HA
    Ann Surg; 1995 Jun; 221(6):721-31; discussion 731-3. PubMed ID: 7794076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of pancreas head carcinoma in a 91-yr-old man. Report of a case successfully treated with pylorus-preserving pancreatoduodenectomy.
    Okamura K; Hayakawa H; Kusagawa M; Takahashi H; Kosaka A; Katsuta K; Mizumoto R
    Int J Pancreatol; 1998 Oct; 24(2):133-8. PubMed ID: 9816548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.
    Zhao Q; Rashid A; Gong Y; Katz MH; Lee JE; Wolf R; Balachandran A; Varadhachary GR; Pisters PW; Wang H; Gomez HF; Abbruzzese JL; Fleming JB; Wang H
    Ann Diagn Pathol; 2012 Jan; 16(1):29-37. PubMed ID: 22050964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
    Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
    Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.